Seikagaku Corporation Stock price
AI Insights on Seikagaku Corporation
Insights
Is Seikagaku Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.
Key metrics
Seikagaku Corporation Stock Analysis
Analyst Opinions
7 Analysts have issued a Seikagaku Corporation forecast:
Analyst Opinions
7 Analysts have issued a Seikagaku Corporation forecast:
Seikagaku Corporation Events
Past Events
|
NOV
10
Q2 2026 Earnings Call
6 days ago
|
Don't miss a Thing! We will send you all news about Seikagaku Corporation directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,075 full-time employees. The company went IPO on 2004-03-23. The firm operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business segment provides reagents for measuring endotoxin.
| Head office | Japan |
| CEO | Mr. Mizutani |
| Employees | 1,144 |
| Website | www.seikagaku.co.jp |


